Welcome to the GAAPP Media & Press Centre. This page provides journalists, media partners, and stakeholders with official press releases, background information, and downloadable communication assets related to GAAPP’s work, events, and advocacy activities worldwide.

Latest Press Releases

Communication Assets

📘 Communication Guide

Download our official brand and communication guidelines.

Download PDF →

📊 Infographics

Disease-specific infographics for Asthma, COPD, and Atopic Dermatitis.

View on Diseases Page →

📋 Fact Sheet

GAAPP at a Glance — Mission, member organizations, and key disease areas.

View About Us →

Multimedia Gallery

Browse highlights from GAAPP events, patient advocacy activities, and global engagements.

×

GAAPP in the News

Coverage of GAAPP’s work across global publications and media outlets.

Publication Title Date
GSK Depemokimab Approved by US FDA for Severe Asthma Dec 16, 2025
The Economist Why the World Can’t Afford to Overlook COPD Sep 2025
Daily News Nigeria Asthma in Africa and the Middle East Sep 12, 2025
The Point (Gambia) Respiratory Diseases Represent Global Burden in Africa Jul 25, 2025
Parade 13 Signs Your Lungs May Not Be Healthy Jul 23, 2025
PR.com GAAPP Press Release Mar 22, 2025
The Point (Gambia) GAAPP Board Member Visits Gambia Jan 22, 2025
Politico EU It’s Time to Address COPD Sep 6, 2024
Politico EU Speaking Up for COPD — A Global Call for Policy Action Nov 15, 2023
BioSpace GAAPP and AstraZeneca SABA Campaign Sep 1, 2020
NCQA Podcast: Reimagining Respiration

Media Contact Information

Media Center FAQ

The Global Allergy & Airways Patient Platform (GAAPP) is an umbrella organization of over 200 patient associations worldwide dedicated to supporting those with respiratory and immunological conditions.

We currently have member organizations across every continent, covering more than 60 countries and representing more than 1 billion patients globally. Learn more about our members or Learn more about Our Members & Regional Groups.

Yes. All assets in our Communication Assets section are cleared for editorial use. Please credit “Global Allergy & Airways Patient Platform (GAAPP)” for all images.

No. GAAPP provides patient advocacy, education, and resources. We do not provide individual medical consultations.

Yes. We can often connect journalists with patient advocates from our member organizations to provide first-hand perspectives on living with respiratory or allergic diseases.